Rybelsus 3 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FRQV4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,173
Award facts
- Contract value 100% obligated
- $23,173.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $23,173.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Rybelsus 3 mg tablets (30-count units) on July 22, 2025, with an ultimate completion date of July 23, 2025. The contract represents a non-competitive delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical supply vehicle running through December 2026. Rybelsus is an oral semaglutide medication indicated for type 2 diabetes management and represents the type of specialty pharmaceutical product delivered through this comprehensive prime vendor arrangement.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, continues to serve as a critical pharmaceutical supplier for federal military and veteran healthcare systems through the DLA Medical Supply Chain. The place of performance is the company's corporate office location in Conshohocken. This delivery order exemplifies the ongoing operational utilization of the SPE2DX contract vehicle, which enables the company to provide diverse pharmaceutical products and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare customers globally. The award reflects the company's sustained capacity to fulfill federal medical procurement requirements on a firm fixed-price basis.
Quick answers
Who was awarded contract SPE2DB25FRQV4?
SPE2DB25FRQV4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 22, 2025.
How much is contract SPE2DB25FRQV4 worth?
The government has obligated $23,173 on SPE2DB25FRQV4.
Is contract SPE2DB25FRQV4 an order under another contract?
Yes. SPE2DB25FRQV4 is a delivery order under SPE2DB20D3101, an indefinite delivery contract.
Was contract SPE2DB25FRQV4 competed?
The extent of competition for SPE2DB25FRQV4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award